title: [Current therapy concepts in patients with multiple myeloma].
authors.affiliation: Klinik für Hämatologie Onkologie und klinische Immunologie, Universität Düsseldorf.
authors.forename: A
authors.initials: A
authors.lastname: Heyll
authors.forename: P
authors.initials: P
authors.lastname: Schneider
authors.forename: U
authors.initials: U
authors.lastname: Bauser
authors.forename: G
authors.initials: G
authors.lastname: Kobbe
authors.forename: A
authors.initials: A
authors.lastname: Hünerlitürkoglu
authors.forename: C
authors.initials: C
authors.lastname: Aul
authors.forename: R
authors.initials: R
authors.lastname: Haas
mesh_terms: D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D010954:Plasmacytoma / Q000532:radiotherapy / Q000628:therapy; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D004164:Diphosphonates; D007376:Interleukin-2; D004921:Erythropoietin; D007372:Interferons